My Macmillan

Publication Details

Need to talk? Call us free*
0800 808 00 00 Monday to Friday, 9am-8pm
Sorafenib (Nexavar®) [Arabic]

Sorafenib (Nexavar®) [Arabic] (March 2017)

Sorafenib is a multi-targeted kinase inhibitor that is used to treat people with kidney, liver, or differentiated thyroid cancer. This factsheet describes how it works, how it is given, and the possible side-effects. Includes the English-language version.

Author(s)
Macmillan Cancer Support
Place of publication
London
Date of publication
March 2017
Pages
14pp
Series
Biological therapies
Price
Free.
Format
Factsheet
Language
Arabic
Download this resource
Need to talk? Call us free*
0800 808 00 00 Monday to Friday, 9am-8pm